• Explore /
  • Poster
  • / FORECAST-1: Feasibility of organoid response assessment to define effective treatments for patients with colorectal cancer after failure of standard therapy.

FORECAST-1: Feasibility of organoid response assessment to define effective treatments for patients with colorectal cancer after failure of standard therapy.

Abstract Poster

Authors

null

Margaret Lee

Eastern Health, Western Health, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia

Margaret Lee , Grace Gard , Jeanne Tie , Niall C. Tebbutt , Tao Tan , Azim Jalali , Belinda Lee , Oliver Sieber , Peter Gibbs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

ACTRN12620001353987

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3583)

DOI

10.1200/JCO.2022.40.16_suppl.3583

Abstract #

3583

Poster Bd #

377

Abstract Disclosures

Similar Posters

First Author: Rosa Berenato

First Author: B. Schultheis

First Author: Jonathan Matthew Hernandez

First Author: Hiromichi Shirasu